ABT - Abbott Laboratories Profile, Stock Quotes, Financial Analysis, Charts, Fundamentals

Abbott Laboratories (ABT)

Other Ticker:

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Price: $107.6200 $1.21

1.137%

Day's High:	$107.75	Week Perf:	-2.91 %
Day's Low:	$ 105.87	30 Day Perf:	1.13 %
Volume (M):	1,979	52 Wk High:	$ 115.14
Volume (M$):	$ 212,980	52 Wk Avg:	$94.24
Open:	$106.67	52 Wk Low:	$61.61

ABT Charts & Quotes

ABT Charts & Quotes

Description of Company's Segments

Market Capitalization (Millions $)	192,409
Shares Outstanding (Millions)	1,788
Employees	77,000
Revenues (TTM) (Millions $)	32,221
Net Income (TTM) (Millions $)	3,382
Cash Flow (TTM) (Millions $)	389
Capital Exp. (TTM) (Millions $)	1,932

Abbott Laboratories
Abbott has five reportable revenue segments: Pharmaceutical Products, Diagnostic Products, Hospital Products, Ross Products, and International. Abbott also has a 50 percent owned joint venture, TAP Pharmaceutical Products Inc.

Company Address: 100 Abbott Park Road Abbott Park 60064 IL
Company Phone Number: 667-6100 Stock Exchange / Ticker: NYSE ABT

ABT is expected to report next financial results on January 27, 2021.

Abbott Laboratories's Segments


Established Pharmaceutical Products	Segment	18.66 %	of total Revenue
Pediatric Nutritionals	Segment	22.97 %	of total Revenue
Adult Nutritionals	Segment	24.83 %	of total Revenue
Nutritionals	Segment	34.74 %	of total Revenue
Endovascular	Segment	7.53 %	of total Revenue
Vascular	Segment	13.05 %	of total Revenue
Diagnostics	Segment	22.45 %	of total Revenue
Other	Segment	11.11 %	of total Revenue

• View Complete Report

	Company Estimates
	• Revenue Outlook Abbott Laboratories does not provide revenue guidance. • Earnings Outlook Abbott Laboratories issued annual earnings guidance on Oct. 21, 2015

Geographic Revenue Dispersion
United States	41.04 %
Japan	6.49 %
Germany	6.55 %
Canada	3.1 %
The Netherlands	5.28 %
Italy	2.92 %
All Other Countries	34.62 %

News

I3 Verticals Inc

Logged a Loss, Topline Tumbles

In the fourth quarter of 2020 I3 Verticals Inc lost money of $-0.06 per share compared to $-0.07 a year ago and increased losses from $-0.02 per share from the previous quarter.

Sales fell sharply by -64.75% to $38.27 millions from $108.56 millions in the same quarter a year ago and sequentially Sales improved by 21.22 % from $31.57 millions.

Meridian Bioscience Inc

Meridian Bioscience Inc announced fourth quarter of 2020 operating profit of $9.474 millions

Meridian Bioscience Inc showed respectable growth in the fourth quarter of 2020, where earnings jumped by 55.77 % year on year to $0.15 per share and Sales increased by 26.17% to $64.15 millions.

Sequentially eps dropped by -76.69% from $0.64 per share and Sales fell by -24.35% from $84.80 millions.

Franklin Resources Inc

Franklin Resources Inc announced fourth quarter of 2020 operating income of $195.9 millions

Franklin Resources Inc faced contraction in eps, despite Sales growth in the fourth quarter of 2020, eps dived by -74.87% to $0.15 per share, while Sales increased in double digits by 12.04% to $1.63 billions, from the same quarter a year ago.

From the preceding quarter, eps dropped by -73.54% from $0.58 per share and Sales surged by 36.98 % from $1.19 billions.

Monmouth Real Estate Investment Corporation

Monmouth Real Estate Investment Corporation announced fourth quarter of 2020 operating surplus of $21.051 millions

Monmouth Real Estate Investment Corporation announced earnings per share of $-0.04 and Sales of $41.78 millions in the fourth quarter of 2020, Company's slipped into loss per share, versus $0.29 eps, earned in the same quarter a year ago, although Monmouth Real Estate Investment Corporation saw its Sales rise by 5.02% in the same period.

Sales increased by 2.06 % from $41.78 millions in preceding period, eps fell from $0.27 per share.

Westrock Company

Fourth quarter Profits vanish on impairment charges

Westrock Company revalues its goodwill and intangible assets, by taking $1,333.20 million charge in the fourth quarter of 2020

Sales contracted by -3.87% to $4.47 billions from $4.65 billions in the same quarter a year ago and sequentially Sales increased by 5.55 % from $4.24 billions.

ABT's Valuation	Current
Price to Earnings PE Ratio (TTM)	56.98
Price to Earnings PE Ratio (Expected)	67.26
Price to Sales (TTM)	5.97
Price to Sales (Expected)	-
Price to Book	6.09
PEG (TTM)	20.95

ABT's Financial Strength	Current
Quick Ratio	0.46
Working Capital Ratio	1.7
Leverage Ratio (MRQ)	0.91
Total Debt to Equity	0.59
Interest Coverage (TTM)	13.26
Debt Coverage (TTM)	0.41

Per Share	Current
Earnings (TTM)	1.89 $
Revenues (TTM)	18.02 $
Cash Flow (TTM)	0.22 $
Cash	2.65 $
Book Value	17.67 $
Dividend (TTM)	1.39 $

ABT's Efficiency	Current
Revenue per Employee (TTM)	418,455
Net Income per Employee (TTM)	43,922
Receivable Turnover Ratio (TTM)	5.99
Inventory Turnover Ratio (TTM)	2.9
Asset Turnover Ratio (TTM)	0.47

ABT's Profitability Ratio	Current
Gross Margin	55.2 %
Operating Margin	16.89 %
Net Margin	13.92 %
Net Cash Flow Margin	-
Effective Tax Rate (TTM)	11.99 %

Management Effectiveness	Current
Return On Assets (TTM)	4.96 %
Return On Investment (TTM)	6.94 %
Return On Equity (TTM)	10.9 %
Dividend Yield	1.33 %
Payout Ratio (TTM)	73.59 %

ABT's Valuation
Price to Earnings PE Ratio (TTM)	56.98
Price to Earnings PE Ratio (Expected)	67.26
Price to Sales (TTM)	5.97
Price to Sales (Expected)	-
Price to Book	6.09
PEG (TTM)	20.95

ABT's Financial Strength
Quick Ratio	0.46
Working Capital Ratio	1.7
Leverage Ratio (MRQ)	0.91
Total Debt to Equity	0.59
Interest Coverage (TTM)	13.26
Debt Coverage (TTM)	0.41

Per Share
Earnings (TTM)	1.89 $
Revenues (TTM)	18.02 $
Cash Flow (TTM)	0.22 $
Cash	2.65 $
Book Value	17.67 $
Dividend (TTM)	1.39 $

• View Valuation Comparisons

• View Growth Rates Comparisons

ABT's Efficiency
Revenue per Employee (TTM)	418,455
Net Income per Employee (TTM)	43,922
Receivable Turnover Ratio (TTM)	5.99
Inventory Turnover Ratio (TTM)	2.9
Asset Turnover Ratio (TTM)	0.47

ABT's Profitability Ratio
Gross Margin	55.2 %
Operating Margin	16.89 %
Net Margin	13.92 %
Net Cash Flow Margin	-
Effective Tax Rate (TTM)	11.99 %

Management Effectiveness
Return On Assets (TTM)	4.96 %
Return On Investment (TTM)	6.94 %
Return On Equity (TTM)	10.9 %
Dividend Yield	1.33 %
Payout Ratio (TTM)	73.59 %

• View Efficiency Comparisons

• View Profitability Comparisons

• View Management Effectiveness

Customers Net Income grew by	ABT's customers Net margin fell to 13.92 %
8.04 %	4.55 %

• Customers Performance

• Customers Expend.

• Customers Efficiency

• List of Customers

Reports on Competition

List of Competitors

Competitors by Segment

Segment Growth

Growth Rates

Suppliers At a Glance

List of Suppliers

Suppliers Performance

Major Competitors

Stock performance

5 Days	Decrease / Increase

LLY		2.81%
JNJ	-2.13%
MRK	-0.66%
PFE		2.87%
BMY		1.55%
ABBV		5.24%
• View Complete Report

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar PPSI's Profile Stock Price PPSI's Financials Business Description Fundamentals Charts & Quotes PPSI's News Suppliers PPSI's Competitors Customers & Markets Economic Indicators PPSI's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Free Stock Market News Feeds

Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071

ABT Company Profile

Logged a Loss, Topline Tumbles

Meridian Bioscience Inc announced fourth quarter of 2020 operating profit of $9.474 millions

Franklin Resources Inc announced fourth quarter of 2020 operating income of $195.9 millions

Monmouth Real Estate Investment Corporation announced fourth quarter of 2020 operating surplus of $21.051 millions

Fourth quarter Profits vanish on impairment charges